Anteilseigner
Capital Research & Management Co. (World Investors) (10,11 %) The Vanguard Group, Inc. (9,26 %) Fidelity Management & Research Co. LLC (7,46 %) Wellington Management Co. LLP (5,70 %) Baillie Gifford & Co. (5,24 %) BlackRock Fund Advisors (4,83 %) Capital Research & Management Co. (International Investors) (2,89 %) T. Rowe Price Associates, Inc. (Investment Management) (2,84 %) SSgA Funds Management, Inc. (2,52 %) Capital Research & Management Co. (Global Investors) (2,49 %) T. Rowe Price Investment Management, Inc. (2,27 %) Norges Bank Investment Management (1,61 %) Geode Capital Management LLC (1,58 %) American Century Investment Management, Inc. (1,09 %) JPMorgan Investment Management, Inc. (0,99 %) Pictet Asset Management SA (0,76 %) Bellevue Asset Management AG (0,73 %) BlackRock Investment Management (UK) Ltd. (0,68 %) Deep Track Capital LP (0,66 %)
Kontakt
Alnylam Pharmaceuticals Inc.
3rd Floor, Third Street 300
02142 Cambridge, MA